Bet Pharma Forms Strategic Deal with Shengsi Bio to Expand Oncology Portfolio in China
Bet Pharmaceuticals partners with Shengsi Bio to expand oncology and chronic disease therapies, boosting its portfolio and market reach in China.
2 minutes to read